secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2022-10-13T23:59:59+00:00
Accession:  0001493152-22-028300
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics closes $5.1M public offering of 3.78M units at $1.35/unit
------------------------------------------------------------------------

- Gross proceeds of $5.1M from offering of 3,777,778 units at $1.35 per unit.
- Each unit includes one common share and three Series A, B, C warrants exercisable at $1.62, $1.35, $2.16 respectively.
- Warrants expire five years from issuance; Series C warrants eligible for cashless exercise upon $10M volume trigger.
- Net proceeds to fund clinical trials, patent portfolio, CRO retention, and working capital.
- WallachBeth Capital acted as sole book-runner; over-allotment option partially exercised for 556,037 warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315222028300/0001493152-22-028300-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315222028300/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-028300

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer